Live Markets: Before the bell: futures up, Lufthansa cuts jobs, GSK CEO steps down

Genmab A/S

29/09/2025 07:57

Adds new blog entry

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com

BEFORE THE BELL: FUTURES UP, LUFTHANSA CUTS JOBS, GSK CEO STEPS DOWN

European shares were set for a higher start on Monday, following gains in Asia and across U.S. futures, with risks of a possible US government shutdown unlikely to weigh on markets too much, although it could delay the release of key data.

Contracts on the EuroSTOXX50, DAX and FTSE indices were last up 0.5-0.6%, with similar gains seen for the S&P 500 and Nasdaq.

In corporate news, Lufthansa LHAG.DE announced 4,000 cuts to administrative jobs by 2030 and set higher profitability targets, as it seeks to boost efficiency.

GSK GSK.L said CEO Emma Walmsley will step down after nine years, to be succeeded by internal candidate Luke Miels.

AstraZeneca AZN.L plans to switch to a direct listing on the New York Stock Exchange, replacing its current ADR structure, while keeping its UK base.

In dealmaking, Denmark's Genmab GMAB.CO agreed to buy Nasdaq-listed Dutch biotech Merus 2GH.F for $8 billion in cash. The firm is developing a head-and-neck cancer drug.

Swiss security firm Verisure is targeting a valuation of up to 13.9 billion euros in its planned Stockholm IPO.

(Danilo Masoni)

****